April 29, 2024European Radiology3 citationsOpen Access

Quantitative assessment of background parenchymal enhancement is associated with lifetime breast cancer risk in screening MRI

RYRan Yan WMWakana Murakami SMShabnam Mortazavi

Key Points

Key points are not available for this paper at this time.

Abstract

To compare the quantitative background parenchymal enhancement (BPE) in women with different lifetime risks and BRCA mutation status of breast cancer using screening MRI.

问 AI

Bookmark

View Full Paper

Cite This Study

Yan et al. (Mon,) studied this question.

synapsesocial.com/papers/68e6d05eb6db64358764e2d3 https://doi.org/https://doi.org/10.1007/s00330-024-10758-9

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Survival outcomes of screening with breast MRI in high-risk women.2017 · 6 citations
2Risks of Breast, Ovarian, and Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers2017 · 2,926 citations
3Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually1989 · 3,395 citations
4Breast MRI contrast enhancement kinetics of normal parenchyma correlate with presence of breast cancer2016 · 40 citations
5Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI2019 · 24 citations

问 AI

Bookmark

View Full Paper